Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), announced that its Simplexa Flu A/B & RSV Direct Kit ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE